HUTCHMED Announces Board of Directors and Board Committee Membership
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or...
News
Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2023
Tokyo, Japan and Cambridge, UK, 12 May 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on...
Mendus AB: Mendus AB (publ) Interim Report January – March 2023
In the first quarter of 2023, Mendus continued on the path set out by the key progress realized at the...
Cellectis Publishes Article in Frontiers in Immunology Unveiling Pre-Clinical Data on a Novel Treatment Paradigm for Successful CAR T Immunotherapy Against Stroma-rich Solid Tumors
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology...
Maylands Dental Centre Launch Free Dental Implant and Invisalign Consultations
Maylands, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- Maylands Dental Centre is a Dentist Perth that has recently launched free implant and...
Admire Dental Butler: Dentist In Butler Launches New Website Under New Management
Butler, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- Admire Dental Butler, a dental clinic that provides a range of oral...
South Perth Dental Surgery: Dentist In South Perth Announces New Customised Dental Implant Solutions
South Perth, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- Founded in 1991, South Perth Dental Surgery is an established Dentist South...
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines...
Better Choice Appoints Kent Cunningham as Chief Executive Officer
NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet...
Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy
An In-Depth Look at Anti-Aging Compound TFC-1326VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM)...
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
OP-1250 in combination with palbociclib was well-tolerated in patients with ER+/HER2- metastatic breast cancer, with no dose-limiting toxicities, and no...
Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
Pivotal top-line data readout expected in mid-2023WARREN, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon”...
Venus Concept Announces 1-for-15 Reverse Stock Split
TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI
– STRIVE is the first Phase 2 sub-protocol trial initiated under Vir’s new PREVAIL platform trial investigating the Company’s novel...
Orion Corporation: Managers’ transactions – Mikael Silvennoinen
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST Orion Corporation: Managers’ transactions – Mikael Silvennoinen Orion Corporation...
Orion Corporation: Managers’ transactions – Agendum Oy
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST Orion Corporation: Managers’ transactions – Agendum Oy Orion Corporation...
Premier Health’s Subsidiary Canadian Health Care Agency Signs 2-year Agreement in British Columbia
MONTRÉAL, May 11, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a...
Grifols Launches AlphaID™ At Home, Enabling U.S. Consumers to Self-Screen for Genetic COPD
Now available in the U.S., this free, innovative genetic health risk service lets consumers screen for their risk of alpha1-antitrypsin...
Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting
ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by...
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
– Significant progress in Comera’s ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Further development of...